Atlas Trials

REGROUP: Renohemodynamic Effects empaGliflozin in vaRiOUs Populations

Clinical trial NCT04243850 · WITHDRAWN

Trial details

NCT number
NCT04243850
Sponsor
Amsterdam UMC, location VUmc
Status
WITHDRAWN
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2Chronic Kidney Diseases
Start date
2020-07-01
Primary completion
2022-03-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.